The Bronx, NY5 Active Studies

Spinal Muscular Atrophy Clinical Trials in The Bronx, NY

Find 5 actively recruiting spinal muscular atrophy clinical trials in The Bronx, NY. Connect with local research sites and explore new treatment options.

5
Active Trials
5
Sponsors
1,084
Enrolling

Recruiting Spinal Muscular Atrophy Studies in The Bronx

NCT06745882Recruiting

Prospective Trial Assessing Real World Outcomes Response to Pembro in Black Patients w/ NSCLC

This is a non-registrational, cohort study enrolling eligible Black patients diagnosed with histologically or cytologically, advanced/metastatic NSCLC without known EGFR/ALK/ROS1 tumor mutations, and ...

The Bronx, NY318 participantsH. Lee Moffitt Cancer Center and Research Institute
View Study Details
NCT04686305Recruiting

Phase Ib Study of the Safety of T-DXd and Immunotherapy Agents With and Without Chemotherapy in Advanced or Metastatic HER2+, Non-squamous NSCLC

DESTINY-Lung03 will investigate the safety and tolerability of trastuzumab deruxtecan in combination with Immunotherapy Agents with and without chemotherapy in patients with HER2 over-expressing non-s...

The Bronx, NY304 participantsAstraZeneca
View Study Details
NCT07288177Recruiting

Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer

This Phase 2 study will be conducted in different countries around the world with up to about 240 participants. The purpose of this study is to evaluate how well Rina-S works against lung cancer. Th...

The Bronx, NY240 participantsGenmab
View Study Details
NCT07227298Recruiting

Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers

This study is being done to learn more about a new medicine called PF-08634404 and how it works when used with other cancer medicines in people who have advanced solid tumors. An advanced solid tumor ...

The Bronx, NY162 participantsPfizer
View Study Details
NCT07057791Recruiting

Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung Cancer

Eligible untreated participants with Extensive Stage Small Cell Lung Cancer (ES-SCLC) who are ≥ 18 years of age will be randomized to receive ivonescimab 10 milligrams per kilogram (mg/kg) or ivonesci...

The Bronx, NY60 participantsPrECOG, LLC.
View Study Details

About Spinal Muscular Atrophy Clinical Trials in The Bronx

Spinal muscular atrophy (SMA) is a genetic neuromuscular disorder that causes loss of motor neurons, leading to progressive muscle weakness and atrophy. It is the leading genetic cause of infant death. Revolutionary gene therapies and SMN-enhancing drugs have transformed treatment.

There are currently 5 spinal muscular atrophy clinical trials recruiting participants in The Bronx, NY. These studies are seeking a combined 1,084 participants. Research is being sponsored by H. Lee Moffitt Cancer Center and Research Institute, AstraZeneca, Genmab and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Spinal Muscular Atrophy Clinical Trials in The Bronx — FAQ

Are there spinal muscular atrophy clinical trials in The Bronx?

Yes, there are 5 spinal muscular atrophy clinical trials currently recruiting in The Bronx, NY. Browse the studies on this page to find one that fits.

How do I join a clinical trial in The Bronx?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the The Bronx research site will contact you about next steps.

Are clinical trials in The Bronx free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many The Bronx studies also compensate for your time and travel.

What spinal muscular atrophy treatments are being tested?

The 5 active trials in The Bronx are testing new therapies including novel drugs, biologics, and treatment approaches for spinal muscular atrophy.

Data updated July 13, 2026 from ClinicalTrials.gov